Opioid Abuse

2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
40/0mg taken firstPhase 21 trial
Active Trials
NCT01030406Completed49Est. Feb 2010
MediciNova
MediciNovaLA JOLLA, CA
1 program
1
MN-166Phase 21 trial
Active Trials
NCT01740414Completed28Est. May 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MediciNovaMN-166
Pfizer40/0mg taken first

Clinical Trials (2)

Total enrollment: 77 patients across 2 trials

Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

Start: Nov 2012Est. completion: May 201728 patients
Phase 2Completed
NCT01030406Pfizer40/0mg taken first

Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users

Start: Jan 2010Est. completion: Feb 201049 patients
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space